202 related articles for article (PubMed ID: 34242895)
1. Apolipoprotein E4, amyloid, and cognition in Alzheimer's and Lewy body disease.
Jung JH; Jeon S; Baik K; Lee YH; Chung SJ; Yoo HS; Jeong SH; Sohn YH; Lee PH; Ye BS
Neurobiol Aging; 2021 Oct; 106():45-54. PubMed ID: 34242895
[TBL] [Abstract][Full Text] [Related]
2. Effect of Alzheimer's Disease and Lewy Body Disease on Metabolic Changes.
Lee YH; Jeon S; Yoo HS; Chung SJ; Jung JH; Baik K; Sohn YH; Lee PH; Yun M; Evans AC; Ye BS
J Alzheimers Dis; 2021; 79(4):1471-1487. PubMed ID: 33459638
[TBL] [Abstract][Full Text] [Related]
3. Differential Vulnerability of Hippocampal Subfields to Amyloid and Tau Deposition in the Lewy Body Diseases.
Ye R; Goodheart AE; Locascio JJ; Peterec E; Properzi M; Thibault EG; Chuba E; Johnson KA; Brickhouse MJ; Touroutoglou A; Growdon JH; Dickerson BC; Gomperts SN
Neurology; 2024 Jun; 102(12):e209460. PubMed ID: 38815233
[TBL] [Abstract][Full Text] [Related]
4. APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer's disease with Lewy body pathology.
Jin Y; Li F; Sonoustoun B; Kondru NC; Martens YA; Qiao W; Heckman MG; Ikezu TC; Li Z; Burgess JD; Amerna D; O'Leary J; DeTure MA; Zhao J; McLean PJ; Dickson DW; Ross OA; Bu G; Zhao N
Acta Neuropathol; 2022 Jun; 143(6):641-662. PubMed ID: 35471463
[TBL] [Abstract][Full Text] [Related]
5. APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloid.
Zhao N; Attrebi ON; Ren Y; Qiao W; Sonustun B; Martens YA; Meneses AD; Li F; Shue F; Zheng J; Van Ingelgom AJ; Davis MD; Kurti A; Knight JA; Linares C; Chen Y; Delenclos M; Liu CC; Fryer JD; Asmann YW; McLean PJ; Dickson DW; Ross OA; Bu G
Sci Transl Med; 2020 Feb; 12(529):. PubMed ID: 32024798
[TBL] [Abstract][Full Text] [Related]
6. Greater Variability in Cognitive Decline in Lewy Body Dementia Compared to Alzheimer's Disease.
Giil LM; Aarsland D
J Alzheimers Dis; 2020; 73(4):1321-1330. PubMed ID: 31903991
[TBL] [Abstract][Full Text] [Related]
7. Association of β-Amyloid and Basal Forebrain With Cortical Thickness and Cognition in Alzheimer and Lewy Body Disease Spectra.
Yoo HS; Jeon S; Cavedo E; Ko M; Yun M; Lee PH; Sohn YH; Grothe MJ; Teipel S; Hampel H; Evans AC; Ye BS
Neurology; 2022 Mar; 98(9):e947-e957. PubMed ID: 34969939
[TBL] [Abstract][Full Text] [Related]
8. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
Sierra M; Gelpi E; Martí MJ; Compta Y
Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
[TBL] [Abstract][Full Text] [Related]
9. β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy.
Shimada H; Shinotoh H; Hirano S; Miyoshi M; Sato K; Tanaka N; Ota T; Fukushi K; Irie T; Ito H; Higuchi M; Kuwabara S; Suhara T
Mov Disord; 2013 Feb; 28(2):169-75. PubMed ID: 23225334
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease.
Qiu WQ; Zhu H; Dean M; Liu Z; Vu L; Fan G; Li H; Mwamburi M; Steffens DC; Au R
Int J Geriatr Psychiatry; 2016 Mar; 31(3):316-22. PubMed ID: 26250797
[TBL] [Abstract][Full Text] [Related]
11. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
Coughlin D; Xie SX; Liang M; Williams A; Peterson C; Weintraub D; McMillan CT; Wolk DA; Akhtar RS; Hurtig HI; Branch Coslett H; Hamilton RH; Siderowf AD; Duda JE; Rascovsky K; Lee EB; Lee VM; Grossman M; Trojanowski JQ; Irwin DJ
Ann Neurol; 2019 Feb; 85(2):259-271. PubMed ID: 30549331
[TBL] [Abstract][Full Text] [Related]
12. α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients.
Daniele S; Baldacci F; Piccarducci R; Palermo G; Giampietri L; Manca ML; Pietrobono D; Frosini D; Nicoletti V; Tognoni G; Giorgi FS; Lo Gerfo A; Petrozzi L; Cavallini C; Franzoni F; Ceravolo R; Siciliano G; Trincavelli ML; Martini C; Bonuccelli U
J Alzheimers Dis; 2021; 80(2):885-893. PubMed ID: 33579836
[TBL] [Abstract][Full Text] [Related]
13. High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.
Vijayaraghavan S; Maetzler W; Reimold M; Lithner CU; Liepelt-Scarfone I; Berg D; Darreh-Shori T
Alzheimers Dement; 2014 Sep; 10(5):530-540.e1. PubMed ID: 23978325
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for earlier dementia onset in autopsy-confirmed Alzheimer's disease, mixed Alzheimer's with Lewy bodies, and pure Lewy body disease.
Schaffert J; LoBue C; White CL; Wilmoth K; Didehbani N; Lacritz L; Nguyen T; Peters ME; Fields L; Li C; Cullum CM
Alzheimers Dement; 2020 Mar; 16(3):524-530. PubMed ID: 32043803
[TBL] [Abstract][Full Text] [Related]
16. No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases.
Maetzler W; Keller S; Michelis J; Koehler N; Stransky E; Becker C; Schulte C; Melms A; Gasser T; Berg D
Neurobiol Dis; 2009 Aug; 35(2):296-301. PubMed ID: 19481150
[TBL] [Abstract][Full Text] [Related]
17. Impact of Apolipoprotein E4 on the Locus Coeruleus Functional Connectivity in Preclinical Alzheimer's Disease.
Um YH; Wang SM; Kang DW; Kim S; Lee CU; Kim D; Choe YS; Kim REY; Lee S; Lee MK; Lim HK
J Alzheimers Dis; 2024; 99(2):705-714. PubMed ID: 38669549
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic Depletion, β-Amyloid Burden, and Cognition in Lewy Body Disease.
Yoo HS; Lee S; Chung SJ; Lee YH; Lee PH; Sohn YH; Lee S; Yun M; Ye BS
Ann Neurol; 2020 May; 87(5):739-750. PubMed ID: 32078179
[TBL] [Abstract][Full Text] [Related]
19. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
[TBL] [Abstract][Full Text] [Related]
20. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
